Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06392269 · ClinicalTrials.gov registry record
A Multi-site Clinical Evaluation of Capillary Blood Samples Collected Using the Tasso+SST Device for Downstream Analyte Testing
A clinical trial, sponsored by Tasso.
- Completed
- Registry status
- 443
- Enrollment target
NCT06392269: Completed study, sponsored by Tasso.
NCT06392269 is a clinical trial that has completed, run by Tasso. The registered enrollment target is 443 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06392269 has completed, sponsored by Tasso.
- COMPLETED
- Registry status
- 443 participants
- Enrollment target
Study Summary
This is a prospective, multi-center study within the U.S. Study participants will take part in two study visits a minimum of 14 days apart. During each visit, participants will self-collect capillary blood samples. Additionally, a healthcare provide will obtain capillary and venous serum samples. All capillary samples will be collected from the upper arm using the Tasso+ device paired with a commercially-available serum separator gel microtainer. The samples will be shipped to a clinical laboratory and tested for various analytes. Expected analyte values for each participant will be based on their venous sample results which will be compared to Tasso sample results
Primary Outcome
To establish the clinical performance of the Tasso+SST device for lay user self-collection and for trained healthcare provider (HCP) collection of capillary blood samples for downstream analyte testing at a clinical laboratory.
Interventions
- DIAGNOSTIC_TEST Tasso+SST
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 443 participants |
| Start Date | 2024-03-18 |
| Est. Completion | 2025-04-15 |
What the finished NCT06392269 record still lists
NCT06392269 is an observational study that tracks outcomes without assigning an intervention. The registered 443 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Tasso+SST is the first listed.
NCT06392269 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06392269 about?
NCT06392269 is a clinical study titled "A Multi-site Clinical Evaluation of Capillary Blood Samples Collected Using the Tasso+SST Device for Downstream Analyte Testing". This is a prospective, multi-center study within the U.S. Study participants will take part in two study visits a minimum of 14 days apart. During each visit, participants will self-collect capillary blood samples. Additionally, a healthcare provide will obtain capillary and venous serum samples. Al...
What is the current status of trial NCT06392269?
This trial is currently completed. The enrollment target is 443 participants. The study started on 2024-03-18. Estimated completion is 2025-04-15.
What interventions are being tested in trial NCT06392269?
The interventions under investigation include: Tasso+SST (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06392269?
This trial is sponsored by Tasso, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06780670 · 443 participants · Phase 2
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- NCT06348394 · 444 participants · NA
Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion
- NCT06700343 · 444 participants · Phase 3
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
- NCT03704766 · 442 participants · NA
Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI